FDA lifts clinical hold on ND0612H and ND0612L for the treatment of Parkinson’s disease
8 May 2015 | By
The FDA has lifted the clinical hold on clinical studies of ND0612H and ND0612L, NeuroDerm's product candidates for the treatment of Parkinson’s disease...